346 related articles for article (PubMed ID: 24570384)
21. [A Case of Lung Cancer Discovered Due to Unresponsive Course of Corticosteroids for Rheumatoid-Associated Interstitial Lung Disease].
Oshita H; Ito N; Senoo M; Funaishi K; Mitama Y; Okusaki K
Gan To Kagaku Ryoho; 2020 Oct; 47(10):1493-1495. PubMed ID: 33130748
[TBL] [Abstract][Full Text] [Related]
22. Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients.
Messina R; Guggino G; Benfante A; Scichilone N
Drugs Aging; 2020 Jan; 37(1):11-18. PubMed ID: 31773418
[TBL] [Abstract][Full Text] [Related]
23. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.
Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review.
Vicente-Rabaneda EF; Atienza-Mateo B; Blanco R; Cavagna L; Ancochea J; Castañeda S; González-Gay MÁ
Autoimmun Rev; 2021 Jun; 20(6):102830. PubMed ID: 33887489
[TBL] [Abstract][Full Text] [Related]
25. Interstitial lung disease in rheumatoid arthritis.
Ascherman DP
Curr Rheumatol Rep; 2010 Oct; 12(5):363-9. PubMed ID: 20628839
[TBL] [Abstract][Full Text] [Related]
26. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
[TBL] [Abstract][Full Text] [Related]
27. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
[TBL] [Abstract][Full Text] [Related]
28. [Rheumatoid arthritis and lung - more than a minor aspect of the disease].
Fiehn C
Dtsch Med Wochenschr; 2015 Jun; 140(12):904-7. PubMed ID: 26069917
[TBL] [Abstract][Full Text] [Related]
29. Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.
Mena-Vázquez N; Godoy-Navarrete FJ; Manrique-Arija S; Aguilar-Hurtado MC; Romero-Barco CM; Ureña-Garnica I; Espildora F; Añón-Oñate I; Pérez-Albaladejo L; Gomez-Cano C; Jimenez-Núñez FG; Padin-Martín MI; Fernández-Nebro A
Clin Rheumatol; 2021 Jan; 40(1):133-142. PubMed ID: 32557255
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate and rheumatoid arthritis associated interstitial lung disease.
Juge PA; Lee JS; Lau J; Kawano-Dourado L; Rojas Serrano J; Sebastiani M; Koduri G; Matteson E; Bonfiglioli K; Sawamura M; Kairalla R; Cavagna L; Bozzalla Cassione E; Manfredi A; Mejia M; Rodríguez-Henriquez P; González-Pérez MI; Falfán-Valencia R; Buendia-Roldán I; Pérez-Rubio G; Ebstein E; Gazal S; Borie R; Ottaviani S; Kannengiesser C; Wallaert B; Uzunhan Y; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Wemeau-Stervinou L; Flipo RM; Marchand-Adam S; Richette P; Allanore Y; Dromer C; Truchetet ME; Richez C; Schaeverbeke T; Lioté H; Thabut G; Deane KD; Solomon JJ; Doyle T; Ryu JH; Rosas I; Holers VM; Boileau C; Debray MP; Porcher R; Schwartz DA; Vassallo R; Crestani B; Dieudé P
Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 32646919
[TBL] [Abstract][Full Text] [Related]
31. The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.
Cavagna L; Monti S; Grosso V; Boffini N; Scorletti E; Crepaldi G; Caporali R
Biomed Res Int; 2013; 2013():759760. PubMed ID: 24205507
[TBL] [Abstract][Full Text] [Related]
32. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
Dai Y; Wang W; Yu Y; Hu S
Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
[TBL] [Abstract][Full Text] [Related]
33. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P
Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364
[TBL] [Abstract][Full Text] [Related]
34. Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis.
Myasoedova E; Matteson EL
Curr Opin Rheumatol; 2024 May; 36(3):203-208. PubMed ID: 38411210
[TBL] [Abstract][Full Text] [Related]
35. The interplay between rheumatic diseases and pulmonary health.
Fedorchenko Y; Zimba O; Yatsyshyn R; Doskaliuk B; Zaiats L; Fedorchenko M
Rheumatol Int; 2024 Jul; 44(7):1179-1184. PubMed ID: 38509351
[TBL] [Abstract][Full Text] [Related]
36. Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease.
Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
Clin Rheumatol; 2016 Oct; 35(10):2585-9. PubMed ID: 27448151
[TBL] [Abstract][Full Text] [Related]
37. Rheumatoid arthritis and lung disease: from mechanisms to a practical approach.
Lake F; Proudman S
Semin Respir Crit Care Med; 2014 Apr; 35(2):222-38. PubMed ID: 24668537
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review.
Picchianti Diamanti A; Markovic M; Argento G; Giovagnoli S; Ricci A; Laganà B; D'Amelio R
Ther Adv Respir Dis; 2017 Jan; 11(1):64-72. PubMed ID: 27733490
[TBL] [Abstract][Full Text] [Related]
39. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study.
Lee SK; Shin K; Jung JY; Suh CH; Kim JW; Kim HA
BioDrugs; 2023 Mar; 37(2):247-257. PubMed ID: 36757601
[TBL] [Abstract][Full Text] [Related]
40. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.
Koduri G; Norton S; Young A; Cox N; Davies P; Devlin J; Dixey J; Gough A; Prouse P; Winfield J; Williams P;
Rheumatology (Oxford); 2010 Aug; 49(8):1483-9. PubMed ID: 20223814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
